A Study on the Use of Real -Time Continuous Glucose Monitoring (RT-CGM) in Gestational Diabetes

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

April 10, 2021

Primary Completion Date

October 1, 2024

Study Completion Date

January 15, 2025

Conditions
Gestational Diabetes
Interventions
DEVICE

Continuous glucose monitor

We are offering you an opportunity to wear a medical device that monitors your blood sugars (glucose). This device is called a continuous glucose monitor (CGM). The CGM measures glucose levels through a tiny plastic filament that is inserted under the skin in your abdomen by a skin prick. Typically, you cannot feel this device once it is inserted.

Trial Locations (1)

98109

University of Washington, Seattle

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

University of Washington

OTHER